Market Overview:
The global Wortmannin market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for Wortmannin in research and medical applications, and increasing investments by key players in the Wortmannin market. Based on type, the global Wortmannin market can be segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The min purity less than 98% segment is expected to account for a major share of the global Wortmannin market during the forecast period. This can be attributed to high demand for low-purity Wortmannin products from research institutes and universities across regions. Based on application, the global Wortmannin market can be divided into research, medical, and others. The medical segment is anticipated to witness significant growth during the forecast period owing to rising use of this compound in cancer treatment therapies.
Product Definition:
Wortmannin is a small molecule inhibitor of the PI3K enzyme family. It was discovered in a screen for inhibitors of the v-Src oncogene. Wortmannin is important because it can inhibit tumor growth and metastasis.
Min Purity Less Than 98%:
Wortmannin is a member of the larger class of pharmaceuticals known as antifibrinolytic agents. The global wortmannin market is expected to grow at an approximate CAGR of XX% over the forecast period. Wortmannin has been used in various therapeutic areas such as gynecology, urology, and cardiology among others; however, it finds its major application in the field of medicine related to brewing and wine making.
Min Purity 98%-99%:
Min Purity 98%-99% is a special type of polypeptide with a purity level of 98.0-99%. It's produced by the ultrafiltration process and has an average molecular weight ranging from 1 to 10 kilodaltons. The product is used in various industries such as pharmaceuticals, research institutes, biotechnology companies for protein purification applications.
The growing demand for high purity proteins.
Application Insights:
Research application dominated the global market with a share of over 80.0% in terms of revenue in 2017. The product is used for the treatment and prevention of various diseases such as asthma, allergic rhinitis, skin infections, urinary tract infections (UTI), gastrointestinal conditions including Crohn¢â‚¬â„¢s disease and ulcerative colitis among others.
The medical segment is expected to witness growth at a CAGR of XX% from 2018 to 2030 owing to increasing product use for various conditions such as kidney stones, bladder infection & UTI among others globally.
Regional Analysis:
Asia Pacific was the largest market in 2016 and is expected to continue its dominance over the forecast period. The region accounts for a major share of global population, which makes it a potential target for various international companies to expand their business in emerging economies. In addition, increasing healthcare spending by governments of developing countries such as China and India are expected to drive the growth during the forecast period.
The demand for wound cleaners across North America is anticipated to grow at an exponential rate owing to rising incidences of chronic wounds such as diabetic foot ulcer and pressure ulcers among others that require specialized care & treatment products. Moreover, stringent government regulations regarding quality standards in pharmaceutical manufacturing are projected to boost product demand over the coming years.
Growth Factors:
- Increasing demand for Wortmannin in the pharmaceutical and biotechnology industries for the treatment of various diseases and disorders.
- Growing research and development activities in the field of Wortmannin drug discovery.
- Rising number of clinical trials being conducted on Wortmannin for its potential therapeutic applications.
- Increasing investments by key players in the global Wortmannin market to expand their product portfolios and strengthen their positions in this market space.
- Technological advancements that are expected to provide novel opportunities for growth of the global Wortmannin market during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Wortmannin Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Biorbyt, Santa Cruz Biotechnology, Merck, Selleck Chemicals, Adooq Bioscience, BioVision, Abcam, TCI, AbMole, LifeSpan BioSciences, BOC Sciences, Focus Biomolecules, Bio-Techne, Cayman Chemical, LGC, Enzo Biochem, Thermo Fisher Scientific, StressMarq Biosciences, Aladdin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Wortmannin Market Report Segments:
The global Wortmannin market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biorbyt
- Santa Cruz Biotechnology
- Merck
- Selleck Chemicals
- Adooq Bioscience
- BioVision
- Abcam
- TCI
- AbMole
- LifeSpan BioSciences
- BOC Sciences
- Focus Biomolecules
- Bio-Techne
- Cayman Chemical
- LGC
- Enzo Biochem
- Thermo Fisher Scientific
- StressMarq Biosciences
- Aladdin
Highlights of The Wortmannin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wortmannin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Wortmannin is a drug that is used to treat ovarian cancer. It works by stopping the growth of cancer cells.
Some of the major players in the wortmannin market are Biorbyt, Santa Cruz Biotechnology, Merck, Selleck Chemicals, Adooq Bioscience, BioVision, Abcam, TCI, AbMole, LifeSpan BioSciences, BOC Sciences, Focus Biomolecules, Bio-Techne, Cayman Chemical, LGC, Enzo Biochem, Thermo Fisher Scientific, StressMarq Biosciences, Aladdin.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Wortmannin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Wortmannin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Wortmannin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Wortmannin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Wortmannin Market Size & Forecast, 2020-2028
4.5.1 Wortmannin Market Size and Y-o-Y Growth
4.5.2 Wortmannin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Wortmannin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Wortmannin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Wortmannin Market: Competitive Dashboard
14.2 Global Wortmannin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biorbyt
14.3.2 Santa Cruz Biotechnology
14.3.3 Merck
14.3.4 Selleck Chemicals
14.3.5 Adooq Bioscience
14.3.6 BioVision
14.3.7 Abcam
14.3.8 TCI
14.3.9 AbMole
14.3.10 LifeSpan BioSciences
14.3.11 BOC Sciences
14.3.12 Focus Biomolecules
14.3.13 Bio-Techne
14.3.14 Cayman Chemical
14.3.15 LGC
14.3.16 Enzo Biochem
14.3.17 Thermo Fisher Scientific
14.3.18 StressMarq Biosciences
14.3.19 Aladdin
